November 2017 | Certara

Publication

Prediction of Olanzapine Exposure in Individual Patients Using Physiologically-based Pharmacokinetic Modeling and Simulation

CertaraNovember 30, 2017

Brochure

D360 Partner

D360 Partner is an affordable add-on product for D360 for external partners that allows for…

CertaraNovember 8, 2017

Publication

Exposure-response of Veliparib to Inform Phase 2 Trial Design in Refractory or Relapsed Patients with Hematological Malignancies

CertaraNovember 1, 2017

© 2025 Certara. All Rights Reserved. | Privacy policy